Regular UPSC news, every day
‹ News Blitz Social Settled

TB death rate falls as India expands diagnosis and treatment

First brief 17 Nov, 5:33 am IST Updated 17 Nov, 5:33 am IST 0 developments 2 min read
TB bacteria under a microscope
CDC/Dr. George P. Kubica · Public domain

Where it stands

India’s Health Ministry reports a 38% fall in the estimated tuberculosis (TB) death rate between 2015 and 2025. The Health Ministry highlighted this finding from WHO’s new global report. The report, released on 12 November 2026, assesses the disease burden and progress in prevention, diagnosis and treatment. India also recorded 94% treatment success among patients with drug-susceptible TB. Tuberculosis is an infectious disease caused by bacteria, usually affecting the lungs. People with infectious lung TB can spread it through the air. Finding patients early allows treatment to begin sooner and helps reduce the opportunity for further transmission. India has expanded screening beyond people who come forward with symptoms. The ministry says its intensified campaign identified nearly 15 lakh cases without symptoms between December 2024 and November 2026. Active screening can therefore find patients before they seek care for symptoms. The mortality trend and treatment results describe progress, while continued diagnosis and care remain central to reducing the remaining burden.

Background

TB can remain undetected when symptoms are mild or absent. Difficulty reaching care can also delay diagnosis. An undiagnosed person may lose time before effective treatment starts. Public-health programmes therefore need both accessible services and ways to find people at risk. Screening is the first search for possible disease. A chest X-ray can identify signs requiring further investigation. A molecular test looks for genetic material from the bacteria and can help confirm TB. Some tests can also identify resistance to medicines, which helps determine the treatment required. Treatment usually requires a combination of medicines over a sustained period. Patient follow-up helps people continue treatment and allows health workers to respond to difficulties. India’s programme combines diagnosis and treatment with nutritional assistance and community support. The Ni-kshay platform helps track patients and their care. A report must measure different stages separately. A death rate relates deaths to population size; incidence counts new episodes of disease. Treatment success concerns outcomes among patients who received treatment. The 94% figure refers to the reported group of drug-susceptible TB patients.

How it developed

  1. 12 November 2026
    How it started

    WHO’s annual assessment measures progress and remaining gaps

    WHO published its annual tuberculosis report using information supplied by national health authorities and other evidence. It assesses the disease burden and progress in prevention, diagnosis and treatment. India’s Health Ministry reported a 38% fall in the estimated TB death rate and 94% treatment success for drug-susceptible TB. It also described expanded X-ray screening, molecular testing, patient follow-up and nutritional support. These are related parts of the response: finding disease, selecting treatment and helping patients complete care.

Why it matters for UPSC

GS2 · Public healthGS3 · Disease diagnosis and treatment

For GS2, explain the links between screening, diagnosis, treatment and public-health outcomes. Distinguish mortality, new cases and treatment success when assessing progress against an infectious disease.

Key terms

TuberculosisAn infectious disease caused by bacteria. It most often affects the lungs but can affect other parts of the body. It is preventable and treatable. Lung TB can spread through the air from a person with infectious disease.
ScreeningChecking people for signs or risks of disease, including people who have not sought care for symptoms. A screening result can identify someone needing further tests. TB programmes use tools such as symptom checks and chest X-rays.
Molecular diagnosisTesting for genetic material from a disease-causing organism. In TB care, rapid molecular tests can detect the bacteria and may identify resistance to particular medicines. This information helps health workers choose suitable treatment.
Drug-susceptible TBTB caused by bacteria that respond to the relevant standard anti-TB medicines. Treatment outcomes for this group are reported separately from drug-resistant TB. The ministry’s 94% success figure refers to drug-susceptible patients.
Treatment successA programme outcome combining patients recorded as cured and those who completed treatment under the reporting definitions. It is measured among a specified treatment group. Understanding that denominator is necessary before interpreting the reported percentage.
Mortality and incidenceMortality concerns deaths; a mortality rate relates them to the population. Incidence measures new episodes of disease during a period. They describe different aspects of the TB burden. Better treatment and efforts to prevent transmission address different parts of that burden.
Ni-kshayIndia’s digital platform for TB programme management. It supports patient notification, tracking and treatment monitoring. It helps health workers maintain continuity of care and connects programme information with patient support.
Sources (3)
Daily news News Blitz Daily quiz Prelims PYQs Live Economic Data Subject notes How to prepare for UPSC Books and NCERTs Syllabus Exam pattern Eligibility and attempts Previous Year Papers Free Downloads Shorts Sign in